financetom
Business
financetom
/
Business
/
PHX Energy Q3 revenue misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PHX Energy Q3 revenue misses estimates
Nov 4, 2025 2:50 PM

Overview

* PHX Energy Q3 revenue grows 2% yr/yr but misses analyst expectations

* Earnings for Q3 decline due to increased depreciation and equipment servicing costs

Outlook

* PHX Energy expects global instability and higher costs to impact future profitability

* Company approved a preliminary 2026 capital expenditure budget of C$60 mln

* PHX Energy plans to expand RSS and Atlas motor rental fleets in 2026

Result Drivers

* US DIVISION GROWTH - US division revenue increased by 3% despite a 7% decline in industry rig count

* HIGHER COSTS - Increased equipment parts and repair costs due to diverse RSS fleet and inflation

* DECREASED HIGH-MARGIN REVENUE - Lower profitability due to decreased RSS activity and motor equipment sales

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss C$164.33 C$175

Revenue mln mln (1

Analyst)

Q3 EPS C$0.16

Q3 C$27.90

Adjusted mln

EBITDA

Q3 FFO C$21.34

mln

Q3 Capex C$16.52

mln

Q3 FFO C$0.46

Per

Share

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the oil & gas drilling peer group is "buy"

* Wall Street's median 12-month price target for PHX Energy Services Corp ( PHXHF ) is C$9.50, about 19.2% above its November 3 closing price of C$7.68

* The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 6 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China Evergrande's liquidators initiate legal action against PwC, FT reports
China Evergrande's liquidators initiate legal action against PwC, FT reports
Aug 6, 2024
Aug 6 (Reuters) - Liquidators of troubled property giant China Evergrande Group ( EGRNF ) have started legal action against PricewaterhouseCoopers, accusing it of negligence and misrepresentation in its work for the group, the Financial Times reported on Tuesday. Lawyers for the liquidators started the court proceedings against PwC Hong Kong and PwC Zhong Tian in March, the report said,...
First Quantum to cut work hours at axed Panama copper mine, union says
First Quantum to cut work hours at axed Panama copper mine, union says
Aug 6, 2024
PANAMA CITY, Aug 6 (Reuters) - First Quantum will reduce working hours at its suspended copper mine in Panama as of next week, a leader of the mine's main labor union, UTRAMIPA, said on Tuesday. The work schedule at Cobre Panama will shift as of Aug. 15, including overtime and Sundays getting cut, said union representative Michael Camacho. First Quantum...
Lender Itau Unibanco reports higher profit, credit acceleration
Lender Itau Unibanco reports higher profit, credit acceleration
Aug 6, 2024
SAO PAULO, Aug 6 (Reuters) - Brazil's Itau Unibanco ( ITUB ) , Latin America's largest private lender, on Tuesday posted second-quarter profit that was up 15.2% from a year earlier, boosted by higher revenues and lower cost of credit. Itau posted a 10.07 billion real net recurring profit ($1.8 billion) for the quarter ended in June, slightly more than...
US FDA says two more doses of Novo Nordisk's weight-loss drug now available
US FDA says two more doses of Novo Nordisk's weight-loss drug now available
Aug 6, 2024
Aug 6 (Reuters) - Two more doses of Novo Nordisk's weight-loss drug, Wegovy, is now available, the U.S. Food and Drug Administration's updated shortages list showed on Tuesday. Several doses of Novo's GLP-1 therapies such as diabetes drug Ozempic and Wegovy, both chemically known as semaglutide, have been on the U.S. health regulator's shortage list since early 2022. According to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved